Kaitlin M. Picard, PMHNP-BC

Massachusetts General Hospital/Harvard Medical School Boston, Massachusetts

  • 3Articles
  • 9.1KReads
  • 2024–2026Active
  • 10Collaborators

About

Kaitlin M. Picard, PMHNP-BC, affiliated with Massachusetts General Hospital and Harvard Medical School, has published extensively on pain, addiction, and psychiatric disorders including depression and posttraumatic stress disorder. Her work focuses on clinical applications of neuromodulatory and wearable technologies for central nervous system disorders, multimodal pain management strategies, and treatment approaches for pain in patients with alcohol and substance use disorders. Picard’s research spans child and adolescent psychiatry as well as broader psychiatric practice.

Publications

PCC
Neuromodulatory Technologies for CNS Disorders
Rounds in the General Hospital

Neuromodulatory Technologies for CNS Disorders

August 13, 2026

Neuromodulatory devices and wearables are transforming psychiatric care; this case-based review covers FDA-approved uses, contraindications, and clinical integration for depression, PTSD, and pain.
, , , et al
PCC
Multimodal Approaches to Pain Management
Rounds in the General Hospital

Multimodal Approaches to Pain Management

June 3, 2025

Although the primary objective of managing acute pain is to provide effective pain relief, it is also important to minimize medication side effects, improve patient function, and reduce the...
, , , et al
PCC
Treatment of Pain in the Context of Alcohol and Substance Use Disorders
Rounds in the General Hospital

Treatment of Pain in the Context of Alcohol and Substance Use Disorders

October 17, 2024

When prescribing opioids for pain, prescription monitoring programs should be checked, regular urine toxicology screening should be conducted, and patients with an opioid use disorder should receive FDA-approved medication...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe